Search - tctmd.com

Displaying 241 - 260 of 3726

Sort: Relevancy | Date

Presentation TCT 2025

TCT 322: Routine Use of Cerebral Embolic Protection Devices During Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials

Presenter: Hasan Ilyas

October 26, 2025

Presentation TCT 2025

TCT 1897: Endovascular Extraction of an Aortic Arch Mass Using Dual Snares and Aspiration Thrombectomy: A Novel Interventional Approach

Presenter: Tobias Geisler

October 26, 2025

Presentation TCT 2025

TCT 1412: Transcatheter Aortic Valve Replacement (TAVR) in a Case With Calcified Right-Dominant Double Aortic Arch

Presenter: Kuan Yu Lin

October 26, 2025

Presentation TCT 2025

TCT 321: Cerebral Embolic Protection Devices in Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials

Presenter: Mostafa Ali

October 26, 2025

Presentation TCT 2025

How Do I Derisk TAVR in Challenging or Previously Treated Aortic Anatomy

Presenter: Oscar A. Mendiz

October 26, 2025

Presentation TCT 2025

Addressing Undertreatment In Aortic Stenosis: Target AS, Detect AS, and Beyond

Presenter: Sammy Elmariah

October 26, 2025

Presentation TCT 2025

From Detection to Early Intervention: Optimizing Active Surveillance with AHA’s Target: Aortic Stenosis

Presenter: Linda D. Gillam

October 26, 2025

Presentation TCT 2025

TCT 640: Diabetes, Glucose Dysregulation, and Inflammatory Biomarkers as Predictors of Mortality and Adverse Events Following Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-analysis

Presenter: Mahsa Rezasoltani

October 26, 2025

Presentation TCT 2025

TCT 643: Treatment of Aortic Stenosis in Patients with Active Cancer: Lifetime Management Considerations

Presenter: Philipp Kiefer

October 26, 2025

Presentation TCT 2025

TCT 644: Impact of Timing of Aortic Valve Replacement Relative to Cancer Therapy on Clinical Outcomes in Patients With Hematologic Malignancy and Severe Aortic Stenosis: A Real‑World Propensity‑Matched

Presenter: Hasnan M. Ijaz

October 26, 2025

Presentation TCT 2025

TCT 75: Repurposing Transthoracic Echocardiogram Predictors of Cardiac Amyloid to Risk Stratify the Severe Aortic Stenosis Population Referred for TAVR

Presenter: Robert Kay

October 26, 2025

Presentation TCT 2025

TCT 1411: HFrEF: A Long-Term Journey Marked by One Narrow Escape After Another

Presenter: Sunanto Ng

October 26, 2025

Presentation TCT 2025

TCT 1410: Safe Passage: Prevention of Left Main Coronary Artery Occlusion During TAVR

Presenter: Ammer Aldairi

October 26, 2025

Presentation TCT 2025

TCT 70: Comparative Outcomes of TAVR vs. SAVR in Patients with Cardiac Amyloidosis and Aortic Stenosis: A Retrospective Matched Cohort Study

Presenter: Shayan Khan

October 26, 2025

Presentation TCT 2025

TCT 1409: Single-Setting Complex PCI and TAVR in Severe AS With Heavily Calcified Anomalous RCA Origin

Presenter: Ying-Hsien Chen

October 26, 2025

Presentation TCT 2025

TCT 1381: TAV in TAV in TAV: Balloon Expandable Valve for Failed Self Expanding Inside of Self Expanding TAVR Valve

Presenter: Robert Stoler

October 26, 2025

Presentation TCT 2025

TCT 117: Contemporary Trends in Mortality and Resource Utilization in Atrial Fibrillation Versus Non-Atrial Fibrillation in Transcatheter Aortic Valve Replacement: A National Study

Presenter: Chaitanya Tumuluri

October 26, 2025

Presentation TCT 2025

TAVR Device Selection Considerations (SMART)

Presenter: Howard C. Herrmann

October 26, 2025

Presentation TCT 2025

SAVR vs. TAVR Strategy Trials (PARTNER 3 and RHEIA)

Presenter: Marvin H. Eng

October 26, 2025

Presentation TCT 2025

TCT 1408: Transcatheter Aortic Valve Replacement (TAVR) and the Left Main Challenge: Risk Stratification and Bailout Strategies

Presenter: Enhua Wang

October 26, 2025

Advertisement

TCT 322: Routine Use of Cerebral Embolic Protection Devices During Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials

TCT 1897: Endovascular Extraction of an Aortic Arch Mass Using Dual Snares and Aspiration Thrombectomy: A Novel Interventional Approach

TCT 1412: Transcatheter Aortic Valve Replacement (TAVR) in a Case With Calcified Right-Dominant Double Aortic Arch

TCT 321: Cerebral Embolic Protection Devices in Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials

How Do I Derisk TAVR in Challenging or Previously Treated Aortic Anatomy

Addressing Undertreatment In Aortic Stenosis: Target AS, Detect AS, and Beyond

From Detection to Early Intervention: Optimizing Active Surveillance with AHA’s Target: Aortic Stenosis

TCT 640: Diabetes, Glucose Dysregulation, and Inflammatory Biomarkers as Predictors of Mortality and Adverse Events Following Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-analysis

TCT 643: Treatment of Aortic Stenosis in Patients with Active Cancer: Lifetime Management Considerations

TCT 644: Impact of Timing of Aortic Valve Replacement Relative to Cancer Therapy on Clinical Outcomes in Patients With Hematologic Malignancy and Severe Aortic Stenosis: A Real‑World Propensity‑Matched

TCT 75: Repurposing Transthoracic Echocardiogram Predictors of Cardiac Amyloid to Risk Stratify the Severe Aortic Stenosis Population Referred for TAVR

TCT 1411: HFrEF: A Long-Term Journey Marked by One Narrow Escape After Another

TCT 1410: Safe Passage: Prevention of Left Main Coronary Artery Occlusion During TAVR

TCT 70: Comparative Outcomes of TAVR vs. SAVR in Patients with Cardiac Amyloidosis and Aortic Stenosis: A Retrospective Matched Cohort Study

TCT 1409: Single-Setting Complex PCI and TAVR in Severe AS With Heavily Calcified Anomalous RCA Origin

TCT 1381: TAV in TAV in TAV: Balloon Expandable Valve for Failed Self Expanding Inside of Self Expanding TAVR Valve

TCT 117: Contemporary Trends in Mortality and Resource Utilization in Atrial Fibrillation Versus Non-Atrial Fibrillation in Transcatheter Aortic Valve Replacement: A National Study

TAVR Device Selection Considerations (SMART)

SAVR vs. TAVR Strategy Trials (PARTNER 3 and RHEIA)

TCT 1408: Transcatheter Aortic Valve Replacement (TAVR) and the Left Main Challenge: Risk Stratification and Bailout Strategies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content